Frontlight ResearchEarly access
CompletedNo phase
Effect of Vojta Therapy on Motor Control in Children With Attention Deficit Hyperactivity Disorder
Key facts
- Who runs it
- Universidad Rey Juan Carlos
- Where
- Spain1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 20 people enrolled
- Started
- 30 Nov 2024
- Ended
- 3 Mar 2025
- Type of study
- Interventional, 2 groups
- Treatments tested
- Vojta Therapy
- No intervetion
- Record updated
- 7 March 2025
Who can take part
- Age
- 6 years to 12 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Have a diagnosis of Attention Deficit Hyperactivity Disorder (ADHD) of the combined or hyperkinetic type
- Be between 6 and 12 years of age
- Be under treatment with methylphenidate
- IQ of 100 or higher
- Have a normal neurological examination
- Not dysmorphic
- Not have received specific physiotherapy treatment for the improvement of balance and postural control in the two months prior to inclusion in the study
Who cannot take part
- Be under treatment with atomoxetine
- Have a history of neurological or musculoskeletal disorders that are linked to a deficit in balance and/or postural control
- Present a diagnosis of ADHD comorbid with other neuropsychiatric pathologies
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
ADHD is generally associated with significant comorbidities including motor disorders in up to 96% of cases. Within these, disturbances of balance and motor coordination that interfere with school learning and daily activities are present in 47% of school children with ADHD. Therefore, the aim of this research is to determine whether Vojta therapy is beneficial for the improvement of balance, postural control, hand-eye coordination and manipulative motor skills in children with ADHD, hyperactive and/or combined, aged 6-12 years.
The 2 groups in the trial
- Experimental groupTreatment being tested
This group is treated according to Vojta therapy
Treatment: Vojta Therapy
- Control groupOther group
This group does not receive treatment
Treatment: No intervetion
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 7 March 2025